Share on LinkedInShare on LinkedIn

ARTICLE · 18 NOVEMBER 2021

Atmofizer Technologies Inc. Closes RTO With Vaxxinator Enterprises Inc.

Gowling WLG
Gowling WLG
Contributor
Gowling WLG

Gowling WLG

The firm The firm’s lawyers speak English, French, Russian and Ukrainian. The firm’s client base...

View firm profile
Explore more from Gowling WLG

On November 15, 2021, Atmofizer Technologies Inc. (formerly Consolidated HCI Holdings Corporation) ("Atmofizer") announced the closing of its previously announced reverse takeover transaction (the "RTO") with Vaxxinator Enterprises Inc.

CanadaCorporate/Commercial Law

On November 15, 2021, Atmofizer Technologies Inc. (formerly Consolidated HCI Holdings Corporation) ("Atmofizer") announced the closing of its previously announced reverse takeover transaction (the "RTO") with Vaxxinator Enterprises Inc. ("Vaxxinator").

The RTO was effected by way of a "three-cornered" amalgamation involving Atmofizer, Vaxxinator and a wholly-owned subsidiary of Atmofizer under the Business Corporations Act (British Columbia). Immediately prior to the amalgamation, Atmofizer consolidated its then Class B shares on 24.691:1 basis, changed its name from "Consolidated HCI Holdings Corporation" to "Atmofizer Technologies Inc." and was continued from a corporation existing under the Canada Business Corporations Act to a company existing under the BCBCA. Concurrent with the Continuance, Atmofizer re-designated its then class B shares to Common Shares.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from